Individualizing Pharmacotherapy for African American Smokers
Status:
Active, not recruiting
Trial end date:
2023-05-30
Target enrollment:
Participant gender:
Summary
Improving cessation outcomes for African American smokers through the use of novel,
empirically-based strategies is a national health priority. In the vast majority of smoking
cessation studies and in clinical practice, when smokers are provided a medication to help
them quit, they are expected to continue that medication regardless of how well it is
working. This study will assess whether African Americans smokers respond better if they
continue with a single treatment or if their treatment is changed when that treatment is not
working.